Revive Spray (CJC-1295 No DAC + Ipamorelin)
|Molar Mass||711.868 g·mol−1|
|Mod grf 1-29/CJC-1295 No Dac|
|Molar Mass||3357.93 g·mol−1|
Revive Spray is a research peptide formulation, blending CJC-1295 No DAC and Ipamorelin. Designed exclusively for research purposes, this innovative combination provides researchers with a valuable tool to explore growth-related processes, potential synergies, and therapeutic applications related to growth hormone regulation.
CJC-1295 No DAC is recognized for its role in stimulating growth hormone release, CJC-1295 No DAC contributes to the blend’s focus on growth-related research. Ipamorelin is known for its growth hormone-stimulating properties, Ipamorelin complements CJC-1295 No DAC in this research formulation.
Revive Spray is formulated for researchers investigating growth-related processes, exploring potential synergies between CJC-1295 No DAC and Ipamorelin, and studying therapeutic applications related to growth hormone regulation.
Potential for Synergistic Benefit
Researchers may explore the combined effects of CJC-1295 No DAC and Ipamorelin, assessing potential synergies in growth-related processes.
Ipamorelin and Weight Gain
Studies may delve into Ipamorelin’s impact on weight gain, providing insights into its metabolic effects.
CJC 1295 No DAC and Treatment of Growth Hormone Deficiency
Researchers are encouraged to investigate the potential therapeutic applications of CJC-1295 No DAC in the treatment of growth hormone deficiency.
Revive Spray (CJC-1295 No DAC + Ipamorelin) is a research peptide formulation designed for scientific exploration into growth-related processes. With a focus on potential synergistic benefits, metabolic effects related to weight gain, and therapeutic applications, this blend provides researchers with a versatile tool for in-depth studies.
- Khavinson VKh. Peptides and Ageing. Neuro Endocrinol Lett. 2002;23 Suppl 3:11-144. PMID: 12374906. [Read More].
- Timms M, Ganio K, Forbes G, Bailey S, Steel R. An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma. Drug Test Anal. 2019 Jun;11(6):804-812. doi: 10.1002/dta.2554. Epub 2018 Dec 25. PMID: 30489688. [Read More].